Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-World's top vaccine maker India criticised at home for exports as infections rise

Tue, 16th Mar 2021 11:58

* India has exported 59 mln vaccine doses

* India has immunised 33 mln people at home

* Infections topped 20,000 for six days in a row

* Total cases at 11.41 mln, with 158,856 deaths
(Adds details)

By Krishna N. Das

NEW DELHI, March 16 (Reuters) - India's main opposition
Congress party on Tuesday hit out at Prime Minister Narendra
Modi's government for exporting nearly twice the number of
coronavirus vaccine doses than immunisations conducted at home,
despite a surge in infections.

India, the world's biggest vaccine maker, has gifted or sold
https://www.mea.gov.in/vaccine-supply.htm 59 million locally
produced doses compared with 33 million doses given to its own
people since its inoculation campaign began in mid-January.

While some rich countries such as the United States are
being accused of vaccine nationalism, India is being lauded
globally for sending shots to 71 countries, mainly the
AstraZeneca vaccine as well as some of Bharat Biotech's
homegrown product.

Many Indians, however, now want the government to make
vaccines available to more of its own people instead of only the
elderly and those above 45 suffering from health conditions.

"The priority of the Modi government is not the state but
foreign nations," Congress said on Twitter, using the tag
#IndiaNeedsMoreVaccines and accusing the premier of focusing on
"PR over people".

"The pace of vaccination in states is slow due to the
centralisation in vaccine distribution," it said.

BALANCE BEING STRUCK

Health Minister Harsh Vardhan told parliament that vaccines
were not being exported at the "expense of the people of India"
and that a balance was being struck.

India's immunisation drive has picked up significantly since
Modi expanded it this month. Still, Bangladesh is vaccinating
more people relative to its population using India-made shots.

India plans to vaccinate 300 million of its 1.35 billion
people by August.

It reported 24,492 new coronavirus cases on Tuesday, the
sixth straight day of more than 20,000 infections.

Total cases have now risen to 11.41 million, the highest
after the United States and Brazil. Deaths increased by 131 to
158,856 in the past 24 hours, data from the health ministry
showed.

The government has blamed crowding and a general reluctance
to wear masks for the spike, ruling out mutations of the virus
as a factor, unlike in the West.

India's worst-affected state, Maharashtra, has ordered
cinemas, hotels and restaurants to limit guests to half of
capacity until the end of the month. Weddings and other social
events will also have limited attendance.

Maharashtra has also locked down some districts.

Another western state, Gujarat, has decided not to allow
fans into the world's biggest cricket stadium hosting
international matches https://www.reuters.com/article/cricket-t20-ind-eng/india-v-england-t20-games-to-go-behind-closed-doors-due-to-covid-19-idUSKBN2B72CF
between India and England, after seeing a spurt in cases.

The initial matches were attended by tens of thousands of
people sitting or standing shoulder to shoulder, with few
wearing masks, leading to widespread criticism on social media.
(Additional reporting by Chandini Monnappa and Rajendra Jadhav;
Editing by Kenneth Maxwell and Gareth Jones)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.